Literature DB >> 8408027

N-acetylglucosaminyltransferase regulates the expression of neolactoglycolipids including sulfoglucuronylglycolipids in the developing nervous system.

D K Chou1, F B Jungalwala.   

Abstract

Lactosylceramide N-acetylglucosaminyltransferase (GlcNac-Tr) in the synthesis of lactotriosylceramide (LcOse3Cer) was characterized in the nervous system. The microsomal membrane GlcNAc-Tr required a divalent metal ion, preferably Mn2+, and a nonionic detergent. The pH optimum was around 7.0. The enzyme also transferred GlcNAc to neolactotetraosylceramide (nLcOse4Cer), GM1, and asialo-GM1, but not to other glycolipids. The Km value for lactosylceramide was 21 microM (Vmax = 91 pmol/mg/h), and that for nLcOse4Cer was 35 microM (Vmax = 112 pmol/mg/h). The GlcNAc-Tr for the glycolipids appears to be separate from that for oligosaccharides. The developmental expression of GlcNAc-Tr, both in the cerebral cortex and cerebellum, correlated well with the tissue levels of LcOse3Cer, nLcOse4Cer, sulfoglucuronylglycolipids (SGGLs), and other neolacto series glycolipids (nLSGs). In the cerebral cortex, the specific activity of GlcNAc-Tr decreased sharply from a maximum level at embryonic day 15, and by postnatal day 10 onward, it was undetectable. In the adult cerebral cortex, although significant activities of other glycosyltransferases involved in the subsequent steps of the synthesis of SGGLs were present, the absence of GlcNAc-Tr stymied the formation of LcOse3Cer and therefore the synthesis of nLSGs, including SGGLs. In the cerebellum, the GlcNAc-Tr specific activity declined from the day of birth to postnatal day 3, but later, the activity increased and reached a maximum at postnatal day 15, which correlated with the increasing synthesis of nLSGs. The results indicate that lactosylceramide GlcNAc-Tr is the key regulatory enzyme controlling the differential expression of all nLSGs in the developing nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.

Authors:  P Fredman; A Lekman
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

2.  Regulation of sulfoglucuronyl glycolipid synthesis in the developing rat sciatic nerve.

Authors:  D K Chou; F B Jungalwala
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

Review 3.  Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review.

Authors:  F B Jungalwala
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

4.  Expression of neolactoglycolipids: sialosyl-, disialosyl-, O-acetyldisialosyl- and fucosyl- derivatives of neolactotetraosyl ceramide and neolactohexaosyl ceramide in the developing cerebral cortex and cerebellum.

Authors:  D K Chou; Y Suzuki; F B Jungalwala
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

5.  The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo.

Authors:  Franziska Biellmann; Andreas J Hülsmeier; Dapeng Zhou; Paolo Cinelli; Thierry Hennet
Journal:  BMC Dev Biol       Date:  2008-11-12       Impact factor: 1.978

6.  B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas.

Authors:  Hang Yeon Jeong; Seo-Young Park; Hyun-Jin Kim; Seungju Moon; Seongsoo Lee; Seung Ho Lee; Sung-Hak Kim
Journal:  CNS Neurosci Ther       Date:  2020-07-16       Impact factor: 5.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.